Cazzato, et al., "Treatment of Multiple Sclerosis. The Present and the Future. Study Group on Diagnosis and Therapy of Multiple Sclerosis", Database Medline on STN, Instituto do Clinica Neurologica, Universit'a, Trieste, Italy: Medline AN: 2000060325, Recent Progressi in Medicina, Oct. 1999, 90(10): 538-544 (Abstract).
Cohen, "Fundamental Immunology", Systemic Autoimmunity, 4th Ed., 1999, 1083.
Fridkis-Hareli et al., "Binding of random copolymers of three amino acids to class II MHC molecules", Intl. Immunol., 1999, 11(5): 635-641.
Kepsutlu et al., "Evaluation of Chitosan Used as an Excipient in Tablet Formulations", Database HCAPLUS on STN, Department of Pharmaceutical Technology, Gulhane Military Medical Academy, Ankara, 06018, Turkey, HCAPLUS AN: 1999: 590411, Acta. Pol. Pharm. 1999, 56(3): 227-235 (Abstract).
Prat, et al., "Lymphocyte Migration and Multiple Sclerosis: Relation with Disease Course and Therapy," Ann. Neurol, 1999, 46: 253-256.
Fridkis-Hareli, et al., "Synthetic Amino Acid Copolymers that Bind to HLA-DR Proteins and Inhibit Type II Collagen-reactive T Cell Clones", Proc. Natl. Acad. Set, Oct. 1998, 95: 12528-12531. Li et al., "Glatiramer acetate blocks the activation of THP-1 cells by interferon-Y", Eur. J. Pharmacol, 1998, 342: 303-310. Zisman et al., "Dichotomy between the T and the B cellepitopes of the synthetic polypeptide (T,G)-A—L", Eur. J. Immunol, 1994, 24(10): 2497-2505 (Abstract).
Deeb et al., "Comparison of Freund's and Ribi adjuvants for inducing antibodies to the synthetic antigen (TG)-AL in rabbits", /. Immunol. Methods, 1992, 152( 1): 105-113 (Abstract). Zisman et al., "Direct binding of a synthetic multichain polypeptide to Class II Major Histocompatibility Complex molecules on Antigen-Presenting Cells and stimulation of a specific T-cell line require processing of the polypeptide", Proc. Natl. Acad. Sci. USA, 1991, 88(21): 9732-9742 (Abstract).
Matsunaga et al., "Complementation of Class II A alleles in the immune response to (Glu-Lys-Tyr) polymers", Yokohama Med. Bull, 1988, 39(1-2): 9-19 (Abstract).
De Kruyff et al., "Analysis of T Cell Responses to Poly-L (GluLys) at the Clonal Level. I. Presence of Responsive Clones in Nonresponder Mice", Eur. J. Immunol, 1987, 17 (8): 1115-1120 (Abstract).
Lai et al., "Complementation of Class II A alleles in the immune response to (GluLysTyr) polymers", Exp. Clin. Immunogenet., 1986, 3(1): 38-48 (Abstract).
Lai et al., "Monoclonal T cell response to two epitopes on a single immunogen controlled by two distinct genes", /. Immunol, 1986, 136(10): 3799-3804 (Abstract).
Trannoy et al., "Epitope-specific regulation of the T cell repertoire: carrier recognition in association with I-E or I-A does not influence the restriction of hapten-specific T cells", Eur. J. Immunol, 1985, 15(12): 1215-1221 (Abstract).
Falo et al., "Analysis of antigen presentation by metabolically inactive accessory cells and their isolated membranes", Proc. Natl. Acad. Sci. USA, 1985 82 (19): 6647-6651 (Abstract). Babu et al., "Ir gene control of T and B Cell Responses to Determinants in (Glu Lys Ala) Terpolymer", J. Immunogenet., 1984, 11(3-4): 251-254.
Babu et al., "Reevaluation of response patterns of nonresponder mice to GLPhe polymers", Immunogen., 1983, 18(1): 97-100 (Abstract).
Herzenberg et al., "Lack of immune response gene control for induction of epitope-specific suppression by TGAL antigen", Nature, 1982, 295: 329-331 (Abstract).
Baxevanis et al., "Genetic Control of T-Cell Proliferative Responses to Poly (Glu40Ala60) and Poly (Glu52Lys34Tyr15): Subregion-Specific Inhibition of the Responses with Monoclonal la Antibodies", Immunogenetics, 1980, 11: 617-628.
Maurer et al., "Interpretations of immune responses of mice to poly(Glu60Lys40), its modified derivatives, and the terpolymers poly (Glu55Lys37Leu8) and poly (Glu56Lys37Ser7)", Clin. Immunol. Immunopathol., 1980, 15(3): 344-356 (Abstract).
Ju et al., "Idiotypic analysis of antibodies against the terpolymer L-glutamic acid 60-L-alanine30-L-tyrosinelO (GAT). IV. Induction of CGAT idiotype following immunization with various synthetic polymers containing glutamic acid and tyrosine", Eur. J. Immunol, 1979, 9(7): 553-560 (Abstract).
Schwartz et al., "Gene complementation in the T lymphocyte proliferative response to poly (Glu57Lys38Tyr5): Evidence for effects of polymer handling and gene dosage", J. Immunol., 1979, 123(1): 272-278 (Abstract).
Aharoni, et al., "Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis", Proc. Natl. Acad. Sci. USA, 1997, 94, 10821-10826.
Aharoni, et al., "Cop 1 Specific Supporessor Cells Inhibit Experimental Allergic Encephalomyelitis Induced by Either Mouse Spinal Cord Homogenate or Proteolipid Protein Peptide 139-151", Neurology, 1997 vol. 48, No. 3, A422.
Aharoni, et al., "Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1", Journal of Neuroimmunology, 1998, 98, 135-146.
Asakura et al., "A unique population of circulating autoantibodies promotes central nervous system remyelination", Multiple Sclerosis, 1998, 4, 217-221.
Asakura et al., "Targeting of IgMk Antibodies to Oligodendrocytes Promotes CNS Remyelination", The Journal of Neuroscience, 1998, 75(19), 1700-1108.
Batchelor, et al., Lancet, 1980 1(8178): 1107-9.
Bieber, et al., "Antibody-mediated remyelination: relevance to
multiple sclerosis", Multiple Sclerosis, 2000, 6(2), S1-S5.
Bieber, et al., "Humoral autoimmunity as a mediator of CNS
repair", A Trends Guide to Neurodegenerative Disease and Repair/
Review, 2001, 24(11), S39-S44.
Bodanszky, M., "Principles of Peptide Synthesis," Springer-Verlag,
Berlin, Heidelberg, New York, Tokyo, 1984, 118-229.
Bornstein, Clinical Experience: Hopeful Prospects In Multiple
Sclerosis, Hospital Practice, 1992, vol. 27, No. 5, pp. 135-158.
Duda, et al., "Human and Murine CD4 T Cell Reactivity to a
Complex Antigen: Recognition of the Synthetic Random
Polypeptide Glatiramer Acetate", The Journal of Immunology,
2000, 165, 7300-7307.
Fatma, et al., Swiss Med. Wkly, 2003, 133:541-543.
Giuseppina, et al., The Journal of Clinical Investigation, Apr. 2003,
vol. Ill, No. 8, 1171-80.
Harrison and Hafler, "Antigen-Specific Therapy for Autoimmune Disease", Current Opin. Immunol, 2000, 12(6): 704-711. Johnson, et al. "Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group", Neurology, 45(7), 1268 (abstract).
Kobayashi, et al., Clinical Exp. Immunology, Jun. 1990, 80(3):4003.
Korezyn, et al., "Safety profile Of copolymer 1: Analysis Of Cumulative Experience in the United States and Israel", J. Neurol, 1996, vol. 243 (Suppl. 1), S23-S26.
Lombardi, et al., /. Invest. Dermatol., Jul. 1999 113(1): 107-10. Lovell, K. and Jones, M., "CNS Infections, Spongiform Encephalopathy and Demyelinating Diseases," Karol Mareinkowski U. Med. Sci., Dept. Pathol., Poland, last updated on Apr. 20, 2003, <URL:http://ampat. amu.edu.pl/guzyuno/ CNS_INFE.HTM>.
Lymberi, etal., Arch. Hellen. Med, 16(4), Jul.-Aug. 1999, 337-351.
McGavern, et al., "Do Antibodies Stimulate Myelin Repair in
Multiple Sclerosis?", The Neuroscientist, 1999, 5(1), 19-28.
Merck Manual of Diagnosis and Therapy, Merck Research Labo-
ratories, Whitehouse Section, N.J., 17th Ed., 1999, 1300-1303,
1312-1317.
Pavelko, et al., "Acceleration in the Rate of CNS Remyelination in
Lysolecifhin-Induced Demyelination", The Journal of
Neuroscience, 1998 18(1), 2498-2505.
Pender, et al., Internal Med. Journal, 2002, 32: 554-563.
Pharmacia Biotech Directory, 1996, pp. 340-341.
Physician's Desk Reference, 2000, Medical Economics Co. Inc., Montvale, NJ, 3115.
Racadot, et al., "Treatment of Multiple Sclerosis With Anti-CD4 Monoclonal Antibody", /. of Autoimmunity, 1993, vol. 6, pp. 771-786.
Rodriguez, et al., "Immunoglobulins Reactive With Myelin Basic Protein Promote CNS Remyelination", Neurology, 1996, vol. 46, pp. 538-545.
Rodriguez, et al., Neurological Therapeutics, 1998, 15(3): 245-250. Sela, M., et al., "Synthetic Approaches to Vaccines for Infectious and Autoimmune Diseases", Vaccine, 1992, vol. 10, Issue 14, 991-999.
Sridama, et al., Arch Intern Med., 1987, 147:229-231.
Teva, et al., "Copolymer-1 Glatiramer Acetate Copaxone Agent for
Multiple Sclerosis". Drugs of the Future, 1998, vol. 23, No. 2,
213-214.
Ure, et al., "Polyreactive Antibodies To Glatiramer Acetate Promote
Myelin Repair In Murine Model Of Demyelinating Diseas", FASEB
Journal, 2002, vol. 16, pp. 1260-1262.
U.S. Appl. No. 10543764, filed Jul. 18, 2005, Aharoni et al.
U.S. Appl. No. 10547463, filed Aug. 30, 2005, Pinchasi et al.
Vandenbark, et al., "Specificity Of T Lymphocyte Lines For Peptide
Of Myelin Basic Protein", The J. Of Immunology, 1985, vol. 135,
pp. 229-233.
Van Noort, et al., International Review of Cytology, 1996, 178: 127-205.
Wan, et al., Human Immunology, 2002, Apr. 63(4):301-10. Warrington, et al., "Immunoglobulin-mediated CNS repair", /. Allergy Clin. Immunol, 2001, S121-S125.
Warrington, et al., "Human monoclonal antibodies reactive to oligodenrocytes promote remyelination in a model of multiple sclerosis", Neurobiology, 2000, 97(12), 6820-6825. Webster's II New Riverside University Dictionary, definition of'preventing", The Riverside Publishing Co., 1984, p. 933. Weilbach, et al., "Disease Modifying Treatments For Multiple Sclerosis: What Is On The Horizon?" CNS Drugs, 1999, vol. 11, No. 2, pp. 133-167.
Wiesemann, et al., "Glatiramer Acetate (GA) induces IL-13/IL-5 secretion in naive T cells", Journal of Neuroimmunology, 2001, 119, 137-144.
Zhang, et al., "Murine Monoclonal Anti-Myelin Basic Protein (MBP) Antibodies Inhibit Proliferation And Cytotoxicity Of MBPspecific human T cells clones", /. of Neuroimmunology, 1989, vol. 24, pp. 87-94.
"About Copaxone", Internet Article URL: http://www.mswatch.
com/therapy/section.aspx?SectionId=789eabf5-3a07-4dff-a7ee
0d4adl38a6d.
URL: http://ntri.tamuk.edu/immunology/autoimmunity.html.
U.S. Appl. No. 10556454, filed Nov. 17, 2005, Vollmer.
U.S. Appl. No. 10577588, filed Apr. 27, 2006, Rosenberger et al.
U.S. Appl. No. 11228850, filed Sep. 14, 2005, Schwartz.
U.S. Appl. No. 11336251, filed Jan. 20, 2006, Dolitzky.
U.S. Appl. No. 11373794, filed Mar. 9, 2006, Pinchasi.
* cited by examiner
|
